Safety of lorlatinib in ALK-positive non-small-cell lung cancer and management of central nervous system adverse events
Future Oncology, Ahead of Print.
Source: Future Oncology - Category: Cancer & Oncology Authors: Saadettin Kilickap Sertac Ak Oldac U Dursun Mehmet AN Sendur Nuri Karadurmus Umut Demirci Source Type: research